Dacetuzumab

Tax included
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research.
MedChemExpress 
HY-P99015

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
Cancer-programmed cell death
CAS
880486-59-9